A liver secretome gene signature-based approach for determining circulating biomarkers of NAFLD severity
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0275901
Abstract: Non-invasive biomarkers of non-alcoholic fatty liver disease (NAFLD) supporting diagnosis and monitoring disease progression are urgently needed. The present study aimed to establish a bioinformatics pipeline capable of defining and validating NAFLD biomarker candidates based… read more here.
Keywords: secretome gene; liver secretome; biomarkers nafld; circulating biomarkers ... See more keywords